Corporate Member Update- Amgen
Corporate Member Update- Amgen
IMDELLTRA® (tarlatamab-dlle)
April, 2025
New Coding Guidance for Amgen Product
IMDELLTRA® (tarlatamab-dlle) received a permanent J-Code J9026, Injection, tarlatamab-dlle, 1 mg
Effective for dates of service on or after January 1, 2025, the Centers for Medicare, and Medicaid Services (CMS) has assigned the following Healthcare Common Procedure Coding Systems (HCPCS) J-Code for IMDELLTRA® J9026, Injection, tarlatamab-dlle, 1 mg
Please see full prescribing information, including BOXED Warnings.
https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Imdelltra/imdelltra_fpi.pdf
